Stay updated with breaking news from Eric Karran. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
After years of setbacks, dementia researchers are getting excited about a new antibody drug called lecanemab. No one expects it to stop cognitive decline, but even slowing it would be a breakthrough
/PRNewswire/ -- Plexium, Inc. (Plexium) and AbbVie (NYSE: ABBV) have entered into an exclusive strategic collaboration to develop and commercialize novel...
Mission and AbbVie Collaboration in Alzheimer’s and Parkinson’s Diseases Reaches Next Milestone
The collaboration agreement will see the development and commercialization of the target, TMEM175 involved in Parkinson's disease and other neurodegenerative conditions.
Capsida Biotherapeutics Debuts with $140 Million of Capital - Versant, Westlake Village BioPartners launch next-generation gene therapy company with $50 million Series A - - Collaboration with AbbVie provides $90 million in up front and equity investment capital to create tissue-targeted gene therapies for three CNS disease targets - News provided by Share this article Share this article THOUSAND OAKS, Calif., April 29, 2021 /PRNewswire/ -- Versant Ventures and Westlake Village BioPartners today announced the emergence from stealth mode of Capsida Biotherapeutics Inc., a biotechnology company...